Search For "biosimilars business"
Biocon Biologics completes acquisition of Viatris' Global Biosimilars Busi
Updated : 3 years, 3 months ago IST
Bengaluru (Karnataka) [India], November 30 (ANI/PRNewswire): Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), announced today that it has successfully completed its multi-billion-dollar (USD) acquisition of the global biosimilars business of its partner Vi
Read More
Biocon Biologics to acquire Viatris' Biosimilars Assets for up to USD 3.33
Updated : 4 years ago IST
Bengaluru (Karnataka) [India], March 1 (ANI/PR Newswire): Biocon Biologics Ltd, a subsidiary of Biocon Ltd (BSE code: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASDAQ: VTRS). Accordingly, Biocon Biologics Ltd (BBL) will acquire Viatris'
Read More
Biocon stock falls 2 pc after 28 pc fall in Q1 net profit
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Shares of Biocon Ltd fell by nearly 2 per cent on Friday morning after the biopharmaceutical major posted 28 per cent fall in its June quarter (Q1 FY21) net profit at Rs 149 crore.
Read More
Biocon Biologics appoints M B Chinappa as new CFO
Updated : 6 years, 2 months ago IST
Bengaluru (Karnataka) [India], Jan 7 (ANI): Biocon Ltd has appointed M B Chinappa as the Chief Financial Officer of its subsidiary Biocon Biologics India Ltd.
Read More
True North to invest Rs 536 crore in Biocon Biologics for 2.4 pc stake
Updated : 6 years, 2 months ago IST
Bengaluru (Karnataka) [India], Jan 6 (ANI): Biopharmaceuticals major Biocon said on Monday the board of its subsidiary Biocon Biologics has approved a primary equity investment by True North which will invest Rs 536.25 crore to pick 2.44 per cent minority stake in the biosimilars business.
Read More